Trace Neuroscience
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$101M
Trace Neuroscience is a biopharmaceutical company developing genomic therapies for neurodegenerative diseases, with a focus on treating amyotrophic lateral sclerosis (ALS) by restoring the UNC13A protein.
Focus Areas
Genomic therapies
Neurodegenerative diseases
ALS
UNC13A protein
Antisense oligonucleotide
Muscle function improvement
Investors
